Nanopore metagenomic sequencing for detection and characterization of SARS-CoV-2 in clinical samples
<strong>Objectives<br></strong> The COVID-19 pandemic has underscored the need for rapid novel diagnostic strategies. Metagenomic Next-Generation Sequencing (mNGS) may allow for the detection of pathogens that can be missed in targeted assays. The goal of this study was to assess t...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
Public Library of Science
2021
|
| _version_ | 1797094972441231360 |
|---|---|
| author | Gauthier, N Nelson, C Bonsall, M Locher, K Charles, M MacDonald, C Krajden, M Chorlton, S Manges, A |
| author_facet | Gauthier, N Nelson, C Bonsall, M Locher, K Charles, M MacDonald, C Krajden, M Chorlton, S Manges, A |
| author_sort | Gauthier, N |
| collection | OXFORD |
| description | <strong>Objectives<br></strong>
The COVID-19 pandemic has underscored the need for rapid novel diagnostic strategies. Metagenomic Next-Generation Sequencing (mNGS) may allow for the detection of pathogens that can be missed in targeted assays. The goal of this study was to assess the performance of nanopore-based Sequence-Independent Single Primer Amplification (SISPA) for the detection and characterization of SARS-CoV-2.
<br><strong>
Methods<br></strong>
We performed mNGS on clinical samples and designed a diagnostic classifier that corrects for barcode crosstalk between specimens. Phylogenetic analysis was performed on genome assemblies.
<br><strong>
Results<br></strong>
Our assay yielded 100% specificity overall and 95.2% sensitivity for specimens with a RT-PCR cycle threshold value less than 30. We assembled 10 complete, and one near-complete genomes from 20 specimens that were classified as positive by mNGS. Phylogenetic analysis revealed that 10/11 specimens from British Columbia had a closest relative to another British Columbian specimen. We found 100% concordance between phylogenetic lineage assignment and Variant of Concern (VOC) PCR results. Our assay was able to distinguish between the Alpha and Gamma variants, which was not possible with the current standard VOC PCR being used in British Columbia.
<br><strong>
Conclusions<br></strong>
This study supports future work examining the broader feasibility of nanopore mNGS as a diagnostic strategy for the detection and characterization of viral pathogens. |
| first_indexed | 2024-03-07T04:21:20Z |
| format | Journal article |
| id | oxford-uuid:cb1f0367-0d6f-4784-845b-8cc7a889b96b |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T04:21:20Z |
| publishDate | 2021 |
| publisher | Public Library of Science |
| record_format | dspace |
| spelling | oxford-uuid:cb1f0367-0d6f-4784-845b-8cc7a889b96b2022-03-27T07:12:45ZNanopore metagenomic sequencing for detection and characterization of SARS-CoV-2 in clinical samples Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:cb1f0367-0d6f-4784-845b-8cc7a889b96bEnglishSymplectic ElementsPublic Library of Science2021Gauthier, NNelson, CBonsall, MLocher, KCharles, MMacDonald, CKrajden, MChorlton, SManges, A<strong>Objectives<br></strong> The COVID-19 pandemic has underscored the need for rapid novel diagnostic strategies. Metagenomic Next-Generation Sequencing (mNGS) may allow for the detection of pathogens that can be missed in targeted assays. The goal of this study was to assess the performance of nanopore-based Sequence-Independent Single Primer Amplification (SISPA) for the detection and characterization of SARS-CoV-2. <br><strong> Methods<br></strong> We performed mNGS on clinical samples and designed a diagnostic classifier that corrects for barcode crosstalk between specimens. Phylogenetic analysis was performed on genome assemblies. <br><strong> Results<br></strong> Our assay yielded 100% specificity overall and 95.2% sensitivity for specimens with a RT-PCR cycle threshold value less than 30. We assembled 10 complete, and one near-complete genomes from 20 specimens that were classified as positive by mNGS. Phylogenetic analysis revealed that 10/11 specimens from British Columbia had a closest relative to another British Columbian specimen. We found 100% concordance between phylogenetic lineage assignment and Variant of Concern (VOC) PCR results. Our assay was able to distinguish between the Alpha and Gamma variants, which was not possible with the current standard VOC PCR being used in British Columbia. <br><strong> Conclusions<br></strong> This study supports future work examining the broader feasibility of nanopore mNGS as a diagnostic strategy for the detection and characterization of viral pathogens. |
| spellingShingle | Gauthier, N Nelson, C Bonsall, M Locher, K Charles, M MacDonald, C Krajden, M Chorlton, S Manges, A Nanopore metagenomic sequencing for detection and characterization of SARS-CoV-2 in clinical samples |
| title | Nanopore metagenomic sequencing for detection and characterization of SARS-CoV-2 in clinical samples |
| title_full | Nanopore metagenomic sequencing for detection and characterization of SARS-CoV-2 in clinical samples |
| title_fullStr | Nanopore metagenomic sequencing for detection and characterization of SARS-CoV-2 in clinical samples |
| title_full_unstemmed | Nanopore metagenomic sequencing for detection and characterization of SARS-CoV-2 in clinical samples |
| title_short | Nanopore metagenomic sequencing for detection and characterization of SARS-CoV-2 in clinical samples |
| title_sort | nanopore metagenomic sequencing for detection and characterization of sars cov 2 in clinical samples |
| work_keys_str_mv | AT gauthiern nanoporemetagenomicsequencingfordetectionandcharacterizationofsarscov2inclinicalsamples AT nelsonc nanoporemetagenomicsequencingfordetectionandcharacterizationofsarscov2inclinicalsamples AT bonsallm nanoporemetagenomicsequencingfordetectionandcharacterizationofsarscov2inclinicalsamples AT locherk nanoporemetagenomicsequencingfordetectionandcharacterizationofsarscov2inclinicalsamples AT charlesm nanoporemetagenomicsequencingfordetectionandcharacterizationofsarscov2inclinicalsamples AT macdonaldc nanoporemetagenomicsequencingfordetectionandcharacterizationofsarscov2inclinicalsamples AT krajdenm nanoporemetagenomicsequencingfordetectionandcharacterizationofsarscov2inclinicalsamples AT chorltons nanoporemetagenomicsequencingfordetectionandcharacterizationofsarscov2inclinicalsamples AT mangesa nanoporemetagenomicsequencingfordetectionandcharacterizationofsarscov2inclinicalsamples |